The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy with limited epidemiological data from Central and Eastern Europe. This study aimed to evaluate long-term trends in UTUC incidence, mortality, and survival in Poland and to compare them with other European countries. Methods: Incidence and mortality data were acquired from Polish National Cancer Registry, Statistics Poland and European Cancer Information System. Age-standardized incidence and mortality rates were calculated using the European Standard Population (ESP 2013). Temporal trends were assessed using Joinpoint regression, and five-year relative survival was estimated with the Pohar–Perme method. Results: Our study demonstrated significantly higher incidence and mortality rates of UTUC across Europe compared to the initial observation period, consistent with the data from Poland. UTUC incidence increased in Poland between 2000 and 2017 (average annual percent change [AAPC] 5.6% in women and 9.9% in men), followed by a decline among women after 2017 (AAPC −1.3%). Mortality initially rose in both sexes but decreased in recent years, particularly in men (AAPC −5.47%). Renal pelvis cancer showed higher incidence and mortality than ureteral cancer. Compared with other European countries, Poland exhibited a smaller gap between incidence and mortality. Five-year relative survival improved over time, reaching 55–56% for renal pelvis cancer and up to 62% for ureteral cancer. Conclusions: UTUC incidence and mortality are rising in Europe, but Poland displays a distinctive epidemiological pattern. Strengthening national cancer registries and implementing centralized care protocols may improve disease management and reduce mortality.
Background/Purpose: Primary urethral cancer is a rare malignancy, accounting for less than 1% of all urogenital cancers. Current epidemiological data from Europe are scarce and outdated. Therefore, the analyzes and comparison of the incidence and mortality of PUC in selected European countries, with particular focus on Poland, based on the most recent available registry data, were performed. Methods: Our study is based on country-level data and is descriptive in nature. Incidence data for PUC were obtained from the national cancer registries of Poland, Latvia, Slovenia, and Hungary. Mortality data were sourced from the WHO Mortality Database. Age-standardized incidence rates were calculated for two time intervals (2000–2009 and 2010–2019). Age-standardized mortality rates for individuals aged ≥45 years were calculated using the European Standard Population (ESP2013). Trends in incidence and mortality in Poland were analyzed using a five-year moving average. Results: The highest incidence of PUC was observed in Hungary, while Poland showed the lowest incidence. Latvia had the highest ASMRs for both sexes, whereas Poland and Greece reported the lowest mortality rates. Despite slight annual fluctuations, the overall PUC mortality rate in Poland has remained stable. Our study is limited by the relatively short analyzed period (2000–2021), restricted availability of C68.0 incidence data from national cancer registries, and incomplete mortality data in the WHO mortality database. Conclusions: This first contemporary comparative analysis of PUC epidemiology in Europe highlights the rarity of this malignancy and the limited data availability. Based on the knowledge drawn from the literature presented in the article on the impact of centralization on the increase in overall survival and the decrease in mortality in rare cancers, the authors believe that centralization of care can improve PUC patient outcomes.
Background/Objectives: Perioperative antibiotics are standard in urethral stricture surgery, but timely uncontaminated preoperative urine cultures are not always available, and empiric regimens are often selected before current susceptibility data are known. We aimed to characterize preoperative bacteriuria and antimicrobial resistance in men undergoing urethral stricture surgery and to assess associations with recorded clinical variables. Methods: We retrospectively analyzed 304 men undergoing urethral stricture surgery at two referral centers, representing the subset of the surgical population for whom a complete preoperative microbiology report, including antimicrobial susceptibility data when culture-positive organisms were recovered, was retrievable from the institutional microbiology laboratory information systems. Clinical contributors were assigned by structured chart review. The primary microbiologic endpoint was preoperative bacteriuria, defined by final local laboratory interpretation of the urine culture. Urine culture was requested at admission and repeated within 24 h before surgery if missing or non-diagnostic. MDR was defined as resistance to three or more clinically relevant antimicrobial classes, excluding expected intrinsic resistance patterns. Results: Among patients with retrievable complete preoperative microbiology data, urine cultures were positive in 164/304 patients (53.9%). The most frequent recorded contributors were iatrogenic exposure (119; 39.1%), prior endoscopic treatment (71; 23.4%), and trauma (64; 21.1%); 108/304 patients (35.5%) had more than one contributor. Among culture-positive patients, MDR occurred in 18/164 (11.0%). On exploratory multivariable analysis, suprapubic catheter status was independently associated with culture positivity (adjusted OR 4.41, 95% CI 2.47–7.87; p < 0.001), whereas PFUI was not significant after adjustment. Conclusions: In this analytic cohort, preoperative bacteriuria was common, and suprapubic catheter status was the strongest independent correlate of urine culture positivity. The observed MDR burden supports recent preoperative urine culture acquisition and stewardship-based perioperative antibiotic selection.